Results 191 to 200 of about 471,786 (305)

Diverging in Vivo Immune Response Patterns After Oral Food Challenge in Peanut Allergic Adults

Clinical &Experimental Allergy, EarlyView.
After the oral food challenge, peanut (PN)‐allergic adults were monitored over 4 weeks, which revealed diverging immune response patterns, with strong responders (SR) exhibiting heightened Ara h 2+ B cell expansion, PN sIgE induction and increasing PN‐specific Tconv. Weak responders (WR) had more activated PN‐specific Tregs.
Florent Fauchère, Aikaterina Alexiou, Veronika Höfer, Kirsten Beyer, Sabine Dölle‐Bierke, Andreas Thiel, Margitta Worm, Julian Braun   +7 more
wiley   +1 more source

Beyond graduation: The journey of a young family doctor in Malaysia. [PDF]

Malays Fam Physician
Nicholson MA.
europepmc   +1 more source

Effects of Common Food Additives Kappa‐, Iota‐ and Lambda‐Carrageenans on Intestinal Epithelial Cell Activation and Barrier Disruption

Clinical &Experimental Allergy, EarlyView.
Carrageenans, widely used food additives, disrupted intestinal epithelial integrity in a gut‐on‐a‐chip model. All types (κ‐, ɩ‐, λ‐) induced cytotoxicity, inflammation and tight junction (TJ) disruption, triggering TNF‐mediated immune responses. λ‐Carrageenan had the most severe effects, supporting the Epithelial Barrier Theory linking food additives ...
Na Sun, Yagiz Pat, Huseyn Babayev, Sena Ardicli, Ismail Ogulur, Xianting Bu, Manru Li, Shuqi Jia, Beate Rückert, Raja Dhir, Kari C. Nadeau, Mubeccel Akdis, Cezmi A. Akdis, Duygu Yazici   +13 more
wiley   +1 more source

Azoospermia/Oligozoospermia and Prostate Cancer Are Increased in Families of Women With Primary Ovarian Insufficiency. [PDF]

J Endocr Soc
Allen-Brady K, Kodama S, Verrilli LE, Ramsay JM, Johnstone EB, Horns JJ, Emery BR, Cannon-Albright L, Aston KI, Hotaling JM, Welt CK.   +10 more
europepmc   +1 more source

Rebound Pruritus and Urticaria After Discontinuation of Chronic Antihistamine Use—A Scoping Review

Clinical &Experimental Allergy, EarlyView.
Rebound pruritus and urticaria have been reported after discontinuation of chronic cetirizine or levocetirizine use only. Symptoms typically occur within 0.5–5 days after stopping therapy and appear more frequently reported in female patients. Re‐initiation of antihistamines is the most commonly effective management strategy, highlighting the need for ...
Jun Jie Benjamin Seng, Prawira Oka, Ngiap Chuan Tan   +2 more
wiley   +1 more source

Breakthroughs of ultrasound-targeted microbubble destruction in treating myocardial ischemia-reperfusion injury: from angiogenesis regulation to precise inflammation suppression. [PDF]

Drug Deliv
Feng W, He P, Wang Z, Li W.
europepmc   +1 more source

Birch Pollen Exposure Boosts Mal d 1‐Specific IgE and Sensitivity to Apple

Allergy, EarlyView.
Alla O. Litovkina, Maria G. Byazrova, Evgenii V. Smolnikov, Alexandra A. Nikonova, Olga G. Elisyutina, Elena S. Fedenko, Nataliya I. Ilina, Oluwatoyin Akinfenwa, Raffaela Campana, Alexander A. Filatov, Musa R. Khaitov, Rudolf Valenta   +11 more
wiley   +1 more source

Johannes Stark und die gescheiterte Erklärung deutscher Nobelpreisträger zur Volksabstimmung vom 19. August 1934. [PDF]

Ber Wiss
Hoffmann D, Kleinert A.
europepmc   +1 more source

Sustained Clinical Improvement in Birch Pollen Allergy After Two Pre‐Seasonal Short Courses of Allergen‐Specific Immunotherapy: A Long‐Term Open‐Label Extension Study

Clinical &Experimental Allergy, EarlyView.
3 years follow‐up study to a DBPC dose‐finding trial investigating subcutaneous immunotherapy with T502 in birch‐pollen induced allergic rhinoconjunctivitis. 154 birch‐pollen allergic adults received short‐course treatment of 10,000 mTU/mL of T502 for 2 years and were observed during the next season without treatment.
Ralph Mösges, Friederike Hüffmeier, Ludger Klimek, Oliver Pfaar, Christian Neuhof, Anna Rybachuk, Cengizhan Acikel, Hacer Sahin, Silke Allekotte, Sandra del Pozo, José Luis Subiza, Miguel Casanovas, Mandy Cuevas, Laura Day, Lea Radtke, Esther Raskopf   +15 more
wiley   +1 more source

Association of Kidney Function With Myocardial Recovery and Adverse Events Following Left Ventricular Assist Device Circulatory Support. [PDF]

J Am Heart Assoc
Bansal N, Maneta E, Zelnick L, Kyriakopoulos CP, Beddhu S, Hartsell S, Stempien-Otero A, Welt F, Tseliou E, Hanff T, Nelson M, Sideris K, Kyriakoulis I, Goldstein J, Mendenhall T, Deol A, Alharethi R, Selzman C, Drakos S.   +18 more
europepmc   +1 more source